Menarini APAC

Menarini APAC is owned by Menarini Group. Menarini Group has a direct presence in 4 countries.

Menarini Group has 3 subsidiaries including Berlin Chemie, Menarini APAC and Stemline Therapeutics.

They are in:

• Pharmaceuticals75%
• Biotechnology25%

View the org chart displaying its 9 main executives

Most searched biographies at Menarini APAC

• Maurizio Luongo, Chief Executive Officer
• Glen Godresse, Chief Marketing Officer & Head of Commercial Excell...
• Jonathan Mullings, General Manager, Australia

Create your alert
to follow the executive moves at Menarini APAC.

Menarini Group has 1,859 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Sanofi (France).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Emma Walmsley - Chief Executive Officer and Director at GSK
• Danilo Cicmil - Supervisory Board Member at Galenika

Learn more about the Pharmaceuticals industry >

Press releases by Menarini APAC

Social media about Menarini APAC

• Menarini APAC on Wikipedia, Google News & Yahoo Finance
• Menarini APAC on LinkedIn, Twitter & YouTube

Contact by email its executives including Maurizio Luongo

Call Menarini APAC at +65 ...

View the org chart

Register to receive your alert

Report an error